Document Detail


Left atrial thrombus and spontaneous echo-contrast in nonanticoagulated mitral stenosis. A transesophageal echocardiographic study.
MedLine Citation:
PMID:  8432117     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The aim of the study was to investigate if evidence at transthoracic echocardiography (TTE) of left atrial (LA) thrombus and LA spontaneous echo-contrast (LA SEC), which are potential precursors of embolization, can be predicted by clinical and TTE variables in nonanticoagulated mitral valve stenosis (MS). DESIGN: Clinical (age, NYHA class, rhythm, previous embolization) and TTE variables were related to transesophageal echocardiography (TEE) evidence of LA thrombus and/or LA SEC. SETTING: Nonanticoagulated MS was the setting. PATIENTS: Fifty-nine patients had MS, and they were not receiving anticoagulant or antiplatelet therapy (24 in sinus rhythm and 35 in atrial fibrillation). Previous arterial embolization had occurred in 12 patients (20.3 percent). MEASUREMENTS: The following TTE variables were analyzed: mitral orifice area (pressure half-time method), mitral gradient (Bernouilli's equation), LA end-systolic area, and mitral regurgitation (color Doppler grading). LA thrombus and LA SEC were analyzed by monoplane TEE. RESULTS: LA thrombus was found by TEE in 12 patients (20.3 percent). Of these 12, 11 (91.6 percent) were in atrial fibrillation. LA SEC was found by TTE in 2 patients (3.5 percent) and by TEE in 40 (67.8 percent) (p < 0.001). Previous embolization had occurred only in patients with LA SEC, of whom 5 had and 7 did not have LA thrombus. Patients with LA SEC, compared with those without LA SEC, were characterized by more frequent advanced NYHA class, atrial fibrillation, smaller mitral valve area, and larger LA size. By multivariate regression analysis, atrial fibrillation and LA end-systolic area were factors related to both LA thrombus and LA SEC, whereas mitral area was related only to LA SEC. However, whereas LA SEC was accurately predicted by the presence of atrial fibrillation (sensitivity: 87.5 percent; specificity: 100 percent) and a LA area > or = 30 cm2 (sensitivity: 72.5 percent; specificity: 89.5 percent), among patients with LA SEC no clinical or TTE variable accurately identified those with actual LA thrombus. CONCLUSIONS: TEE is not necessary in many patients with MS in order to recognize LA SEC. However, when actual LA thrombus detection is necessary for clinical decision making, TEE should be performed.
Authors:
C Vigna; V de Rito; G M Criconia; A Russo; M Testa; R Fanelli; F Loperfido
Related Documents :
2306147 - Surgical treatment of automatic atrial tachycardias.
7830327 - Atrial demand pacing in patients with symptomatic sick sinus syndrome.
8911237 - Status of antithrombotic therapy for patients with atrial fibrillation in university ho...
12923337 - Paradoxical therapy in conversion reaction.
1799787 - A 5-year experience with 307 ct-guided renal biopsies: results and complications.
21515247 - Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients s...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chest     Volume:  103     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  1993 Feb 
Date Detail:
Created Date:  1993-03-12     Completed Date:  1993-03-12     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  348-52     Citation Subset:  AIM; IM    
Affiliation:
Department of Cardiology, Ospedale Casa Sollievo della Sofferenza, IRCSC, San Giovanni Rotondo, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Anticoagulants / therapeutic use
Echocardiography*
Female
Heart Atria / ultrasonography
Heart Diseases / complications,  ultrasonography*
Humans
Male
Middle Aged
Mitral Valve Stenosis / complications,  ultrasonography*
Thrombosis / complications,  ultrasonography*
Chemical
Reg. No./Substance:
0/Anticoagulants
Comments/Corrections
Comment In:
Chest. 1993 Feb;103(2):331-2   [PMID:  8432112 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pneumothorax. Results of thoracoscopy and pleurodesis with talc poudrage and thoracotomy.
Next Document:  Effects of a bronchoprovocation challenge test with cigarette sidestream smoke on sensitive and heal...